These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 18703653)
41. Biotechs hedge against big pharma givebacks. Dorey E Nat Biotechnol; 1999 May; 17(5):416-7. PubMed ID: 10331784 [No Abstract] [Full Text] [Related]
42. Proposed guidelines for housestaff interaction with pharmaceutical companies. Forrest DM; Ruedy J Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243 [TBL] [Abstract][Full Text] [Related]
43. Small gifts, conflicts of interest, and the zero-tolerance threshold in medicine. Krimsky S Am J Bioeth; 2003; 3(3):50-2. PubMed ID: 14594492 [No Abstract] [Full Text] [Related]
44. Doctors, medical societies and the pharmaceutical industry. Mayers I Can Respir J; 2002; 9(5):297-8, 301-2. PubMed ID: 12410321 [No Abstract] [Full Text] [Related]
45. US senator seeks information about medical faculty links to drug industry. Tanne JH BMJ; 2009 Jul; 339():b2725. PubMed ID: 19581320 [No Abstract] [Full Text] [Related]
46. Relationships with the drug industry: Keep at arm's length. Angell M BMJ; 2009 Feb; 338():b222. PubMed ID: 19193614 [No Abstract] [Full Text] [Related]
47. Industry funding in medical education. Davies P Lancet; 2002 Jun; 359(9321):1949-50. PubMed ID: 12057586 [No Abstract] [Full Text] [Related]
48. [Commercialization of the medical research is a reality. What is the limit?]. Naeser K Ugeskr Laeger; 2005 Oct; 167(43):4103; author reply 4103-5. PubMed ID: 16251105 [No Abstract] [Full Text] [Related]
49. [Keep medical education independent! It should not be a scene of drug industry marketing]. Eliasson G; HÃ¥kansson J Lakartidningen; 2001 Sep; 98(39):4168-9. PubMed ID: 11680148 [No Abstract] [Full Text] [Related]
50. Medical education and the pharmaceutical industry: managing an uneasy alliance. Jibson MD Acad Psychiatry; 2006; 30(1):36-9. PubMed ID: 16473992 [No Abstract] [Full Text] [Related]
51. [Clinical practice and pharmaceutical industry: an always difficult relationship]. Mastai R Acta Gastroenterol Latinoam; 2005; 35(4):209-10. PubMed ID: 16496851 [No Abstract] [Full Text] [Related]
52. The role of public and private institutions in medical research. Bloch H Proc R Soc Med; 1968 Jul; 61(7):696-9. PubMed ID: 5664298 [No Abstract] [Full Text] [Related]
54. Drug company payments: Put declaration in abstracts. Stanton R BMJ; 2008 Feb; 336(7640):345. PubMed ID: 18276678 [No Abstract] [Full Text] [Related]
59. Medical professionalism--focusing on the real issues. Ruane TJ N Engl J Med; 2000 Sep; 343(10):739-40. PubMed ID: 10979775 [No Abstract] [Full Text] [Related]
60. Interacting with the pharmaceutical industry. Greenwald M CMAJ; 1994 Sep; 151(6):731; author reply 732. PubMed ID: 8087745 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]